WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen WargackiChief Science Officer2025-03-104,572$2.54
$11.61kSell
Cassie JungChief Operating Officer2025-03-102,182$2.54
$5.54kSell
Daniel BarberPresident and CEO2025-03-0953,998$2.65
$143.09kSell
Stephen WargackiChief Science Officer2025-03-0915,431$2.65
$40.89kSell
Peter E. BoydSVP Information Technology Human Resources and Communications2025-03-097,681$2.65
$20.35kSell
Cassie JungChief Operating Officer2025-03-097,997$2.65
$21.19kSell
A. Ernest Toth Jr.Chief Financial Officer2025-03-098,736$2.65
$23.15kSell
Lori J. BraenderChief Legal Officer2025-03-0910,658$2.65
$28.24kSell
A. Ernest Toth Jr.Chief Financial Officer2025-03-0710,193$2.65
$27.01kSell
Stephen WargackiChief Science Officer2025-03-0712,859$2.65
$34.08kSell

1 of 2

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP9.92%9,810,958$24.63MInstitution
Blackrock Inc6.07%5,998,598$15.06MInstitution
Vanguard Group Inc4.40%4,346,754$10.91MInstitution
Vr Adviser LLC2.66%2,629,786$6.60MInstitution
Franklin Resources Inc2.16%2,134,796$5.36MInstitution
Douglas K. Bratton1.99%1,963,890$4.93MInsider
Geode Capital Management LLC1.67%1,654,596$4.15MInstitution
Mpm Bioimpact LLC1.63%1,611,833$4.05MInstitution
State Street Corp1.52%1,503,891$3.77MInstitution
Daniel Barber1.03%1,015,173$2.55MInsider

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST43.87%7.62%Net SellingNet Selling
EBS41.15%58.85%Net SellingNet Selling
ACB8.84%0.00%
LFCR49.98%50.02%Net Buying
TKNO11.93%63.98%Net Buying
View Top Pharmaceutical Stocks

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 43.87% institutional shareholders, 7.62% Aquestive Therapeutics insiders, and 48.51% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.99% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $5.07M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.